CD8A and melanoma: In 2019, Martinez-Usatorre et al. reported that expression of miR-155 depends on the presence of CD8+ T cells in tumour infiltrating lymph nodes, and low levels of miR-155 are associated with longer overall survival (OS) in melanoma patients [28].